Krystal Biotech Inc (KRYS)
156.67
-3.08
(-1.93%)
USD |
NASDAQ |
Jan 08, 16:00
155.88
-0.79
(-0.50%)
After-Hours: 20:00
Krystal Biotech SG&A Expense (Quarterly): 28.71M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 220.99M |
| Amicus Therapeutics Inc | 75.11M |
| Insmed Inc | 118.93M |
| Rhythm Pharmaceuticals Inc | 35.38M |
| Apellis Pharmaceuticals Inc | 121.98M |